Contract 75A50223C00043
Maxim Biomedical, Inc · Department Of Health And Human Services · September 20, 2023
Maxim Biomedical, Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 20, 2023 for $49.54 million of work in in-vitro diagnostic substance manufacturing. Performance is in Rockville, MD. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 6, 2024.
Contract details
- PIID
- 75A50223C00043
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Optical Instruments, Test Equipment, Components And Accessories
- Place of performance
- Rockville, MD
- First action
- September 20, 2023
- Latest action
- November 6, 2024
Description
OVER THE COUNTER (OTC) COVID-19 TESTS
Modification timeline
-
November 6, 2024Mod P00004$0
-
June 5, 2024Mod P00003$0
-
April 5, 2024Mod P00002$0
-
November 3, 2023Mod P00001$0
-
September 20, 2023Base award$49.54M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50223C00043?
Contract 75A50223C00043 is a federal contract awarded to Maxim Biomedical, Inc by Department Of Health And Human Services on September 20, 2023 for $49.54 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 75A50223C00043?
Maxim Biomedical, Inc won contract 75A50223C00043 from Department Of Health And Human Services.
How much is contract 75A50223C00043 worth?
Contract 75A50223C00043 has obligated $49.54 million to date.